| Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors (NCT00007813) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-05-31 |
| Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (NCT00005049) | NYU Langone Health | 1997-05-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer (NCT00003072) | University of California, San Francisco | 1997-05-01 |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract (NCT00003334) | NYU Langone Health | 1997-03-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer (NCT00002931) | City of Hope Medical Center | 1997-02-01 |
| Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer (NCT00019136) | National Cancer Institute (NCI) | 1997-02-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer (NCT00002928) | Memorial Sloan Kettering Cancer Center | 1997-01-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003064) | Herbert Irving Comprehensive Cancer Center | 1997-01-01 |
| Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission (NCT00002977) | Fred Hutchinson Cancer Center | 1997-01-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer (NCT00003136) | University of Chicago | 1996-12-01 |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function (NCT00002901) | City of Hope Medical Center | 1996-12-01 |
| Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer (NCT00002819) | Gynecologic Oncology Group | 1996-11-01 |
| Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease (NCT00001503) | National Cancer Institute (NCI) | 1996-09-19 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer (NCT00003080) | Fred Hutchinson Cancer Center | 1996-09-01 |
| Clinical Significance of Germline BRCA Mutations (NCT00579488) | Memorial Sloan Kettering Cancer Center | 1996-07-01 |
| Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer (NCT00003214) | Swiss Cancer Institute | 1996-07-01 |
| Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer (NCT00002895) | Medical Research Council | 1996-06-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer (NCT00003002) | University of Washington | 1996-04-01 |
| Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer (NCT00002717) | Gynecologic Oncology Group | 1996-03-01 |
| Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer (NCT00002734) | National Cancer Institute (NCI) | 1996-03-01 |
| Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer (NCT00002894) | Medical Research Council | 1996-03-01 |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer (NCT00019084) | National Cancer Institute (NCI) | 1996-02-01 |
| Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer (NCT00002671) | NYU Langone Health | 1995-12-01 |
| A Follow-up Study of Women Evaluated and Treated for Infertility (NCT00342446) | National Cancer Institute (NCI) | 1995-10-01 |
| Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers (NCT00608452) | Memorial Sloan Kettering Cancer Center | 1995-07-01 |
| Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer (NCT00002903) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-07-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy (NCT00270166) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-02-01 |
| Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer (NCT00002600) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1994-10-21 |
| Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas (NCT00019019) | National Institutes of Health Clinical Center (CC) | 1994-10-01 |
| Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer (NCT00002568) | Gynecologic Oncology Group | 1994-06-01 |
| A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 (NCT00001383) | National Cancer Institute (NCI) | 1994-03-01 |
| Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin (NCT00002559) | Memorial Sloan Kettering Cancer Center | 1994-01-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors (NCT00002558) | Memorial Sloan Kettering Cancer Center | 1994-01-01 |
| Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers (NCT00002538) | Gynecologic Oncology Group | 1993-09-01 |
| Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer (NCT00002478) | Gynecologic Oncology Group | 1993-06-01 |
| Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer (NCT00002943) | Wake Forest University Health Sciences | 1993-02-01 |
| Chemotherapy in Treating Patients With Advanced Sarcoma (NCT00002526) | Swiss Cancer Institute | 1993-01-01 |
| Melphalan in Patients With Neoplastic Meningitis (NCT00002750) | Duke University | 1992-12-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |
| Genetic Studies in Breast Cancer (NCT00582322) | Memorial Sloan Kettering Cancer Center | 1992-02-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors (NCT00002489) | Memorial Sloan Kettering Cancer Center | 1991-10-01 |
| Combination Chemotherapy in Treating Patients With Sarcoma (NCT00662233) | Mayo Clinic | 1991-10-01 |
| Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer (NCT00002487) | Ottawa Regional Cancer Centre | 1991-07-01 |
| Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer (NCT00002477) | Medical Research Council | 1991-04-01 |
| Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer (NCT00002474) | Loyola University | 1991-02-01 |
| Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT00002508) | Temple University | 1990-11-01 |
| Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors (NCT00276718) | Children's Cancer and Leukaemia Group | 1989-04-01 |
| Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer (NCT04473833) | John R van Nagell | 1988-12-19 |
| Examining the Long-Term Risks of Oophorectomy (NCT00655447) | Parker, William H., M.D. | 1980-01-01 |
| Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer (NCT00093678) | Eastern Cooperative Oncology Group | |
| Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer (NCT00189579) | ARCAGY/ GINECO GROUP | |
| Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer (NCT01606358) | Rennes University Hospital | |
| A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy (NCT00189358) | AGO Study Group | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval (NCT06751524) | Agenus Inc. | |
| Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 (NCT00477867) | Gynecologic Oncology Group | |
| An Expanded Access Program for AM0010 (Pegilodecakin) (NCT03554434) | Eli Lilly and Company | |
| Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission (NCT00693342) | Gynecologic Oncology Group | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248) | Leap Therapeutics, Inc. | |
| Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer. (NCT03079687) | AstraZeneca | |
| Expanded Access of Vigil in Solid Tumors (NCT03842865) | Gradalis, Inc. | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00006235) | Gynecologic Oncology Group | |
| Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393) | xCures | |
| Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer (NCT00055432) | Eli Lilly and Company | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003939) | European Organisation for Research and Treatment of Cancer - EORTC | |
| Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer (NCT00006267) | Gynecologic Oncology Group | |